| Independent Reports (Showing 1 to 9 of 9) |
Release Date ![[down]](http://us.i1.yimg.com/us.yimg.com/i/fi/down.gif) |
Contributor |
Author |
Title |
Pages |
Price |
More Info |
| 24-May-13 | Ford Investor Services, Inc. | N/A | Value Graph: TALON THERAPEUT -- TLON | 1 | $11.50 | View Abstract |
| 24-May-13 | Ford Investor Services, Inc. | N/A | Industry Value Graph: EXAS , GNBT , HEB , INSM , TLON -- DRUGS | 3 | $34.50 | View Abstract |
| 23-May-13 | Plunkett Research, Ltd. | Jack W Plunkett | Talon Therapeutics, Inc. (TLON) Profile and Financials, plus Biotechnology Industry Trends Analysis, Operating Ratios and Financial Averages | 48 | $99 | View Abstract |
| 21-May-13 | GlobalData | GlobalData | Talon Therapeutics, Inc. (TLON) - Pharmaceuticals & Healthcare - Deals and Alliances Profile | 43 | $250 | View Abstract |
| 17-May-13 | Reuters Investment Profile | N/A | Talon Therapeutics Inc: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis. | 12 | $138 | View Abstract |
| 11-May-13 | S&P Capital IQ Quantitative Report | N/A | Talon Therapeutics | 5 | $57.50 | View Abstract |
| 8-Apr-13 | GlobalData | GlobalData | Talon Therapeutics, Inc. (TLON) - Financial and Strategic SWOT Analysis Review | 35 | $125 | View Abstract |
| 5-Apr-13 | Pechala's Reports | Frantisek Pechala | TALON THERAPEUTICS INC (TLON) 12-months forecast | 1 | $15 | View Abstract |
| 4-Apr-13 | Streetwise Reports | N/A | 6 Biotechs with Staggering Potential: Grant Zeng | 12 | $115 | View Abstract |